Thursday, April 23, 2026 | 07:41 PM ISTहिंदी में पढें
Welcure Drugs & Pharmaceuticals Ltd
Submission Of Disclosure Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirement
03:37 PM, 15th Feb 2023
With reference to the above subject the provision of the Regulation 32 of SEBI (LODR) Regulations2015 the Statement of Deviation or Variation for proceeds of public issue rights issue preferential issue QIP is not applicable to our Company for the quarter ended 31st December 2022.